Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17881895 | 0.88 | RIPK1 (0.84) | RIPK1FKBP1A | |
| SCHEMBL17881977 | 0.88 | RIPK1 (0.84) | RIPK1FKBP1A | |
| SCHEMBL19367188 | 0.87 | RIPK1 (0.50) | RIPK1FKBP1A | |
| SCHEMBL17881971 | 0.84 | RIPK1 (0.82) | RIPK1FKBP1A | |
| SCHEMBL18510351 | 0.84 | FKBP1A (0.52) | RIPK1FKBP1A | |
| SCHEMBL28536599 | 0.83 | RIPK1 (0.80) | RIPK1FKBP1A | |
| SCHEMBL19367191 | 0.80 | FKBP1A (0.62) | FKBP1A | |
| SCHEMBL19367186 | 0.80 | FKBP1A (0.62) | FKBP1A | |
| SCHEMBL18510347 | 0.80 | FKBP1A (0.62) | FKBP1A | |
| SCHEMBL17881984 | 0.79 | RIPK1 (1.00) | RIPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210100772-A1 | METHODS FOR TREATING ALOPECIA AND ACHROMOTRICHIA | DAVID WEINSTEIN CONSULTING INC (US) | 2021-04-08 | — | — | US | disclosed |
| US-20200276157-A1 | COMPOSITIONS AND METHODS FOR TREATING ALOPECIA | DAVID WEINSTEIN CONSULTING INC (US) | 2020-09-03 | — | — | US | disclosed |
| US-20200276158-A1 | COMPOSITIONS AND METHODS FOR TREATING ALOPECIA | DAVID WEINSTEIN CONSULTING INC (US) | 2020-09-03 | — | — | US | disclosed |
| US-10709686-B2 | Methods for treating pulmonary fibrosis | DAVID WEINSTEIN CONSULTING, INC. (US) | 2020-07-14 | — | — | US | disclosed |
| US-20190290612-A1 | METHODS FOR TREATING PULMONARY FIBROSIS | DAVID WEINSTEIN CONSULTING INC (US) | 2019-09-26 | — | — | US | disclosed |
| US-10363240-B2 | Compositions and methods for treating alopecia | DAVID WEINSTEIN CONSULTING, INC. (US) | 2019-07-30 | — | — | US | disclosed |
| US-20190216777-A1 | COMPOSITIONS AND METHODS FOR TREATING ALOPECIA | DAVID WEINSTEIN CONSULTING INC (US) | 2019-07-18 | — | — | US | disclosed |
| US-20190216775-A1 | COMPOSITIONS AND METHODS FOR TREATING ALOPECIA | DAVID WEINSTEIN CONSULTING INC (US) | 2019-07-18 | — | — | US | disclosed |
| US-10285977-B2 | Compositions and methods for treating alopecia | DAVID WEINSTEIN CONSULTING, INC. (US) | 2019-05-14 | — | — | US | disclosed |
| US-20180140576-A1 | METHODS FOR WOUND HEALING AND SCAR PREVENTION | DAVID WEINSTEIN CONSULTING INC (US) | 2018-05-24 | — | — | US | disclosed |
| US-20180140577-A1 | COMPOSITIONS AND METHODS FOR TREATING ALOPECIA | DAVID WEINSTEIN CONSULTING, INC. | 2018-05-24 | — | — | US | disclosed |
| US-20180140577-A1 | COMPOSITIONS AND METHODS FOR TREATING ALOPECIA | DAVID WEINSTEIN CONSULTING, INC. | 2018-05-24 | — | — | US | disclosed |
| US-20180140576-A1 | METHODS FOR WOUND HEALING AND SCAR PREVENTION | DAVID WEINSTEIN CONSULTING INC (US) | 2018-05-24 | — | — | US | disclosed |
| WO-2017165119-A1 | METHODS FOR WOUND HEALING AND SCAR PREVENTION | WEINSTEIN DAVID (US) | 2017-09-28 | — | — | WO | disclosed |
| US-20170266157-A1 | METHODS FOR WOUND HEALING AND SCAR PREVENTION | DAVID WEINSTEIN CONSULTING, INC. | 2017-09-21 | — | — | US | disclosed |
| US-20170266157-A1 | METHODS FOR WOUND HEALING AND SCAR PREVENTION | DAVID WEINSTEIN CONSULTING, INC. | 2017-09-21 | — | — | US | disclosed |
| US-20170202805-A1 | COMPOSITIONS AND METHODS FOR TREATING ALOPECIA | DAVID WEINSTEIN CONSULTING, INC. | 2017-07-20 | — | — | US | disclosed |
| US-20170202805-A1 | COMPOSITIONS AND METHODS FOR TREATING ALOPECIA | DAVID WEINSTEIN CONSULTING, INC. | 2017-07-20 | — | — | US | disclosed |
| US-20170042859-A1 | COMPOSITIONS AND METHODS FOR TREATING ALOPECIA | DAVID WEINSTEIN CONSULTING, INC. | 2017-02-16 | — | — | US | disclosed |
| US-20170042859-A1 | COMPOSITIONS AND METHODS FOR TREATING ALOPECIA | DAVID WEINSTEIN CONSULTING, INC. | 2017-02-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (14 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170042859-A1 | COMPOSITIONS AND METHODS FOR TREATING ALOPECIA | S100A4, FKBP4, FKBP5 | RIPK1 2210/4885FKBP1A 5/4885 |
| US-10285977-B2 | Compositions and methods for treating alopecia | S100A4, FKBP4, FKBP5 | RIPK1 2210/4885FKBP1A 5/4885 |
| US-10709686-B2 | Methods for treating pulmonary fibrosis | FKBP4, FKBP1B, FKBP3 | RIPK1 2164/4885FKBP1A 7/4885 |
| US-20170202805-A1 | COMPOSITIONS AND METHODS FOR TREATING ALOPECIA | S100A4, FKBP4, FKBP5 | RIPK1 2210/4885FKBP1A 5/4885 |
| US-20190216777-A1 | COMPOSITIONS AND METHODS FOR TREATING ALOPECIA | S100A4, FKBP4, FKBP5 | RIPK1 2210/4885FKBP1A 5/4885 |
| US-20200276158-A1 | COMPOSITIONS AND METHODS FOR TREATING ALOPECIA | S100A4, FKBP4, FKBP5 | RIPK1 2210/4885FKBP1A 5/4885 |
| US-20190216775-A1 | COMPOSITIONS AND METHODS FOR TREATING ALOPECIA | S100A4, FKBP4, FKBP5 | RIPK1 2210/4885FKBP1A 5/4885 |
| US-20180140577-A1 | COMPOSITIONS AND METHODS FOR TREATING ALOPECIA | S100A4, FKBP4, FKBP5 | RIPK1 2210/4885FKBP1A 5/4885 |
| US-20180140576-A1 | METHODS FOR WOUND HEALING AND SCAR PREVENTION | FKBP4, S100A4, FKBP14 | RIPK1 2439/4885FKBP1A 5/4885 |
| US-20170266157-A1 | METHODS FOR WOUND HEALING AND SCAR PREVENTION | FKBP4, S100A4, FKBP14 | RIPK1 2439/4885FKBP1A 5/4885 |
| US-20200276157-A1 | COMPOSITIONS AND METHODS FOR TREATING ALOPECIA | S100A4, FKBP4, FKBP5 | RIPK1 2210/4885FKBP1A 5/4885 |
| US-20210100772-A1 | METHODS FOR TREATING ALOPECIA AND ACHROMOTRICHIA | CYP17A1, CYP21A2, MITF | RIPK1 3613/4885FKBP1A 46/4885 |
| US-10363240-B2 | Compositions and methods for treating alopecia | S100A4, FKBP4, FKBP5 | RIPK1 2210/4885FKBP1A 5/4885 |
| US-20190290612-A1 | METHODS FOR TREATING PULMONARY FIBROSIS | FKBP4, FKBP1B, FKBP3 | RIPK1 2164/4885FKBP1A 7/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.